Can the combination of ALSFRS and survival time analysis impact the outcome in phase III ALS clinical trials?

about

Can the combination of ALSFRS and survival time analysis impact the outcome in phase III ALS clinical trials?

Item

http://www.wikidata.org/entity/Q44231416

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Can the combination of ALSFRS ...... phase III ALS clinical trials?

@en

Can the combination of ALSFRS ...... phase III ALS clinical trials?

@nl

type

Item

label

Can the combination of ALSFRS ...... phase III ALS clinical trials?

@en

Can the combination of ALSFRS ...... phase III ALS clinical trials?

@nl

prefLabel

Can the combination of ALSFRS ...... phase III ALS clinical trials?

@en

Can the combination of ALSFRS ...... phase III ALS clinical trials?

@nl

P1476

Can the combination of ALSFRS ...... phase III ALS clinical trials?

@en

P2093

Raghav Govindarajan

http://www.w3.org/2001/XMLSchema#string

P2860

Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.

Disease progression in amyotrophic lateral sclerosis: predictors of survival.

Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402.

Quality of life in patients with amyotrophic lateral sclerosis: perceptions, coping resources, and illness characteristics.

Comparison of analysis approaches for phase III clinical trials in amyotrophic lateral sclerosis.

Electrical impedance myography as a biomarker for ALS.

Relationship between ALS and the degree of cognitive impairment, markers of neurodegeneration and predictors for poor outcome. A prospective study.

P304

779

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MUS.23728

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23532832

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

phase III clinical trial